Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2020 | Challenges associated with CAR-T cell production

Valentín Ortiz-Maldonado • 24 Aug 2020
EBMT 2020
Diffuse Large B-Cell Lymphoma Lymphoma Non-Hodgkin Lymphoma CAR-T

Valentín Ortiz-Maldonado, MD, Hospital Clínic de Barcelona, Barcelona, Spain, discusses challenges associated with CAR-T cell production. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Valentín Ortiz-Maldonado

1:26
The major benefits of producing academic CAR T-cells
Valentín Ortiz-Maldonado • 10 Dec 2023
3:03
The impact of salvage and bridging therapy on CAR T-cell therapy outcomes in B-ALL: an ITT analysis
Valentín Ortiz-Maldonado • 10 Dec 2023
2:58
Var-cel shows promise for the treatment of CLL and Richter's transformation
Valentín Ortiz-Maldonado • 10 Dec 2023
2:25
Efficacy of varnimcabtagene autoleucel in patients with R/R BCL with no indication for CAR-T therapy
Valentín Ortiz-Maldonado • 8 Jun 2023

Related Videos

1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
2:28
Checkpoint inhibitors vs brentuximab vedotin as salvage therapy prior to alloSCT for HL
Jacopo Mariotti • 15 Apr 2024
1:37
Exciting CAR-T clinical trials in LBCL and FL
Gloria Iacoboni • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals